The United States Supreme Court delivered a significant ruling on Thursday, June 25, 2026, in favor of Bayer AG, drastically reducing the company’s exposure to lawsuits alleging that its Roundup weedkiller causes cancer due to inadequate warnings. In a 7-2 decision, the High Court determined that federal law preempts, or overrides, state-level claims that Bayer failed to warn consumers about the cancer risks associated with glyphosate, the active ingredient in Roundup.
This ruling marks a major victory for the German pharmaceutical and life sciences company, which acquired Monsanto, the original maker of Roundup, in 2018. The decision is expected to lead to the dismissal of numerous existing warning-based claims and prevent future lawsuits predicated on similar state-level failure-to-warn arguments.
Supreme Court’s Preemption Ruling on FIFRA
The Supreme Court‘s majority opinion, authored by Justice Brett Kavanaugh, asserted that the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) preempts state-level failure-to-warn claims. FIFRA is a federal law that governs the registration, distribution, sale, and use of pesticides, requiring the Environmental Protection Agency (EPA) to regulate these products.
Justice Kavanaugh explained that because the EPA has consistently deemed glyphosate safe for use when applied properly and has not mandated a cancer warning label, FIFRA’s provisions for uniform labeling requirements take precedence. He stated, “With respect to pesticide labels, FIFRA demands ‘[u]niformity’ and expressly preempts state labeling requirements that are ‘in addition to’ or ‘different from’ federal labeling requirements.”
The ruling further clarified that state tort law, which allows individuals to sue for civil wrongs, cannot impose labeling requirements that are either additional to or different from those established under federal FIFRA mandates. This interpretation aligns with the Trump administration’s stance, which had argued for the preemption of such state-level claims. The US Supreme Court backs federal regulators in various cases, often reinforcing federal authority.
The John Durnell Case and Its Reversal
The specific case that reached the Supreme Court involved John Durnell, who claimed his cancer resulted from repeated exposure to glyphosate and that Bayer had failed to warn him of these risks. A Missouri jury in 2019 awarded Durnell more than 1 million USD, finding in his favor on the failure-to-warn claim.
A Missouri appeals court subsequently affirmed this judgment, upholding the jury’s verdict. However, the Supreme Court’s decision on Thursday reversed that judgment and remanded the case, meaning it sent the case back to the lower courts for reconsideration in light of the new federal preemption ruling. This effectively nullifies Durnell’s previous victory based on state law.
The implications of this reversal extend far beyond Durnell’s individual claim. It places a significant number of similar failure-to-warn cases against Bayer, concerning the alleged Roundup cancer risk, in immediate legal jeopardy. This development could reshape how farmers face new legal hurdles in Roundup lawsuits.
Bayer’s Financial Gains and Broader Litigation Impact
Bayer promptly celebrated the Supreme Court’s decision on Thursday, issuing a statement that hailed the ruling as beneficial for science, farmers, and industries reliant on regulatory clarity for innovation. The company expressed confidence that the decision would significantly contain the Roundup litigation, which has spanned nearly a decade of legal battles.
Bayer anticipates that the ruling will result in the dismissal of current warning-based claims and effectively bar future failure-to-warn claims. The financial markets reacted positively to the news, with Bayer’s shares rising by 15.75% to 13.09 USD following the announcement of the ruling. This surge reflects investor confidence in the reduced legal and financial risks for the company.
The ruling provides a measure of certainty for Bayer regarding a substantial portion of its ongoing legal challenges related to Roundup. However, it does not necessarily resolve all litigation, as other types of claims not directly related to failure-to-warn under state law might still proceed. For more details on the ruling, see this CNBC report on the Supreme Court decision.
Dissenting Views and Political Repercussions
The Supreme Court’s decision was not unanimous, with Justice Ketanji Brown Jackson filing a dissenting opinion, joined by Justice Neil Gorsuch. Justice Jackson argued that the majority’s holding departed from the near-unanimous view of many state and federal courts that had previously rejected this preemption argument.
She contended that Durnell’s failure-to-warn claim was not ‘in addition to or different from’ FIFRA’s mandates, but rather ‘equivalent to FIFRA’s key labeling requirement – the misbranding prohibition.’ The misbranding prohibition under FIFRA ensures that pesticide labels are not false or misleading, implying that a failure to warn of a known risk could constitute misbranding.
Beyond the legal sphere, the ruling carries potential political consequences for the Trump administration. The decision is seen as a significant blow to the Make America Healthy Again (MAHA) movement, which played a role in President Donald Trump’s return to the White House in the 2024 election. MAHA activists, who had supported Trump after Robert F. Kennedy Jr. (now Health and Human Services Secretary) endorsed the President, have expressed feelings of betrayal.
Robert F. Kennedy Jr. himself had previously won a similar case in 2018 for a man who claimed Monsanto failed to warn of glyphosate’s cancer risk. MAHA advocate Kelly Ryerson, known online as ‘Glyphosate Girl,’ reacted strongly on X, stating, “Today’s SCOTUS ruling is historic. Never in history has an administration so blatantly and willingly sold out our fertility, vitality, and health to corporate interests.’ She added, ‘It is unforgivable. We will make sure all voters know exactly how this domestic chemical attack happened.” The Democrats Supreme Court threat discourse often highlights such politically charged rulings.
This ruling also reignites the long-standing debate surrounding glyphosate’s safety. In 2015, the World Health Organization’s International Agency for Research on Cancer (IARC) classified glyphosate as ‘probably carcinogenic to humans,’ a finding that contrasts with the U.S. EPA’s consistent position of not requiring such a label. The US Supreme Court poised to rule on various contentious issues, and this decision adds to the list of rulings with broad societal impact.